December 8, 2021
PCI Biotech: Update on regulatory interactions for the RELEASE trial
Oslo (Norway), 7 December 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company…
Pharmaceuticals, Biotechnology and Life Sciences
Oslo (Norway), 7 December 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company…
Combined testing from two contracts averages 1,000 PCR samples per dayTesting potential for the two contracts could ramp up to…
Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patientsMENLO PARK, Calif.,…
Sorrento has received accreditation from the American College of Pathologists, which allows Sorrento to bill to Medicare and MedicaidSAN DIEGO,…
Bavarian Nordic A/S (“Bavarian Nordic” or the “Company”) announced its intention to raise new capital through an accelerated bookbuilding process.…
BOSTON, Dec. 06, 2021 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and…
-Workforce reduction of 65% -Prioritization of lead program TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in…
PHILADELPHIA, Dec. 06, 2021 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (Nasdaq: CNTX) (“Context Therapeutics” or the “Company”), a women’s oncology…
— Recruitment of 687 patients globally completed in fifteen months, ahead of schedule — — FRESCO-2 primary objective is to confirm overall…
Endpoint in Line with FDA Guidance on Key Outcomes in High-Risk Patients and with Pharma Industry Drugs Approved for Cardiovascular…